Suppr超能文献

在没有 RNA 测序数据的情况下鉴定人类黑色素瘤细胞系中的可变剪接。

Identification of Alternative Splicing in Proteomes of Human Melanoma Cell Lines without RNA Sequencing Data.

机构信息

V.L. Talrose Institute for Energy Problems of Chemical Physics, N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, 119334 Moscow, Russia.

Federal Research and Clinical Center of Physical-Chemical Medicine, 119435 Moscow, Russia.

出版信息

Int J Mol Sci. 2023 Jan 27;24(3):2466. doi: 10.3390/ijms24032466.

Abstract

Alternative splicing is one of the main regulation pathways in living cells beyond simple changes in the level of protein expression. Most of the approaches proposed in proteomics for the identification of specific splicing isoforms require a preliminary deep transcriptomic analysis of the sample under study, which is not always available, especially in the case of the re-analysis of previously acquired data. Herein, we developed new algorithms for the identification and validation of protein splice isoforms in proteomic data in the absence of RNA sequencing of the samples under study. The bioinformatic approaches were tested on the results of proteome analysis of human melanoma cell lines, obtained earlier by high-resolution liquid chromatography and mass spectrometry (LC-MS). A search for alternative splicing events for each of the cell lines studied was performed against the database generated from all known transcripts (RefSeq) and the one composed of peptide sequences, which included all biologically possible combinations of exons. The identifications were filtered using the prediction of both retention times and relative intensities of fragment ions in the corresponding mass spectra. The fragmentation mass spectra corresponding to the discovered alternative splicing events were additionally examined for artifacts. Selected splicing events were further validated at the mRNA level by quantitative PCR.

摘要

选择性剪接是活细胞中除了简单的蛋白质表达水平变化之外的主要调控途径之一。蛋白质组学中提出的大多数用于鉴定特定剪接异构体的方法都需要对研究样本进行初步的深度转录组分析,但并非总是可行,特别是在对先前获得的数据进行重新分析的情况下。在此,我们开发了新的算法,用于在缺乏研究样本 RNA 测序的情况下,从蛋白质组学数据中鉴定和验证蛋白质剪接异构体。生物信息学方法在先前通过高分辨率液相色谱和质谱(LC-MS)获得的人类黑色素瘤细胞系的蛋白质组分析结果上进行了测试。针对每个研究的细胞系,在从所有已知转录本(RefSeq)和包含所有生物学上可能的外显子组合的肽序列组成的数据库中,对选择性剪接事件进行了搜索。使用对相应质谱中碎片离子的保留时间和相对强度的预测对鉴定进行了过滤。对发现的选择性剪接事件的碎裂质谱进行了额外的伪影检查。选择的剪接事件进一步通过定量 PCR 在 mRNA 水平上进行了验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a9c/9916885/3220391970e5/ijms-24-02466-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验